{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:57:25Z","timestamp":1792526245022,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["10430072110010"],"award-info":[{"award-number":["10430072110010"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127549","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T12:21:03Z","timestamp":1753446063000},"page":"127549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Strengthening spontaneous reporting-based signal detection during a pandemic with cases from electronic health records using a natural language processing tool"],"prefix":"10.1016","volume":"62","author":[{"given":"W.","family":"van der Weg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"von Kreijfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zwaveling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.E.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.P.A.M.","family":"van Hunsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Kant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2025.127549_bb0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40264-022-01253-5","article-title":"Optimizing safety surveillance for COVID-19 vaccines at the National Pharmacovigilance Centre Lareb: one year of COVID-19 vaccine experience","volume":"46","author":"Oosterhuis","year":"2023","journal-title":"Drug Saf."},{"key":"10.1016\/j.vaccine.2025.127549_bb0010","author":"European mMedicines aAgency (EMA)"},{"key":"10.1016\/j.vaccine.2025.127549_bb0015","author":"European mMedicines aAgency (EMA)"},{"key":"10.1016\/j.vaccine.2025.127549_bb0020","author":"European mMedicines aAgency (EMA)"},{"key":"10.1016\/j.vaccine.2025.127549_bb0025","author":"European Medicines Agency (EMA)"},{"key":"10.1016\/j.vaccine.2025.127549_bb0030","author":"European mMedicines aAgency (EMA)"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127549_bb0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"27","key":"10.1016\/j.vaccine.2025.127549_bb0040","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10277","key":"10.1016\/j.vaccine.2025.127549_bb0045","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(21)00432-3","article-title":"Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127549_bb0050","article-title":"Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots","volume":"372","author":"Wise","year":"2021","journal-title":"Bmj"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127549_bb0055","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40264-014-0240-1","article-title":"A description of signals during the first 18 months of the EMA pharmacovigilance risk assessment committee","volume":"37","author":"Pacurariu","year":"2014","journal-title":"Drug Saf."},{"issue":"3","key":"10.1016\/j.vaccine.2025.127549_bb0060","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/pds.3395","article-title":"Evaluation of FDA safety-related drug label changes in 2010","volume":"22","author":"Lester","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.vaccine.2025.127549_bb0065","article-title":"Global covid-19 vaccine rollout and safety surveillance-how to keep pace","volume":"373","author":"Lo Re","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.vaccine.2025.127549_bb0070","author":"European mMedicines aAgency (EMA)"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127549_bb0075","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40264-023-01302-7","article-title":"Factors associated with underreporting of adverse drug reactions by health care professionals: a systematic review update","volume":"46","author":"Garc\u00eda-Abeijon","year":"2023","journal-title":"Drug Saf."},{"issue":"8","key":"10.1016\/j.vaccine.2025.127549_bb0080","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40264-023-01325-0","article-title":"Use of electronic health record data for drug safety signal identification: a scoping review","volume":"46","author":"Davis","year":"2023","journal-title":"Drug Saf."},{"issue":"1","key":"10.1016\/j.vaccine.2025.127549_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10916-024-02070-2","article-title":"An innovative method to strengthen evidence for potential drug safety signals using electronic health records","volume":"48","author":"Abedian Kalkhoran","year":"2024","journal-title":"J. Med. Syst."},{"key":"10.1016\/j.vaccine.2025.127549_bb0090","author":"CTcue"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127549_bb0095","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1111\/bcp.14831","article-title":"Liver and kidney function in patients with Covid-19 treated with remdesivir","volume":"87","author":"van Laar","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"21","key":"10.1016\/j.vaccine.2025.127549_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215426","article-title":"Application of electronic health record text mining: real-world tolerability, safety, and efficacy of adjuvant melanoma treatments","volume":"14","author":"van Laar","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127549_bb0105","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/cpt.1966","article-title":"An electronic health record text mining tool to collect real-world drug treatment outcomes: a validation study in patients with metastatic renal cell carcinoma","volume":"108","author":"van Laar","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.vaccine.2025.127549_bb0110","series-title":"Reporting adverse drug reactions: Definitions of terms and criteria for their use","author":"Bankowski","year":"1999"},{"key":"10.1016\/j.vaccine.2025.127549_bb0115","author":"Netherlands pharmacovigilance centre Lareb"},{"key":"10.1016\/j.vaccine.2025.127549_bb0120","author":"Netherlands pharmacovigilance centre Lareb"},{"key":"10.1016\/j.vaccine.2025.127549_bb0125","author":"European Medicine Agency (EMA)"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127549_bb0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40264-023-01375-4","article-title":"Appeal for increasing the impact of pharmacovigilance","volume":"47","author":"Kant","year":"2024","journal-title":"Drug Saf."},{"issue":"1","key":"10.1016\/j.vaccine.2025.127549_bb0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00228-022-03419-7","article-title":"Impact of suspected adverse drug reactions on mortality and length of hospital stay in the hospitalised patients: a meta-analysis","volume":"79","author":"Patel","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"7456","key":"10.1016\/j.vaccine.2025.127549_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"Bmj"},{"issue":"15","key":"10.1016\/j.vaccine.2025.127549_bb0145","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies","volume":"279","author":"Lazarou","year":"1998","journal-title":"Jama"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127549_bb0150","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/pds.5246","article-title":"Signals from the Dutch national spontaneous reporting system: characteristics and regulatory actions","volume":"30","author":"van Hunsel","year":"2021","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"3","key":"10.1016\/j.vaccine.2025.127549_bb0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40264-024-01495-5","article-title":"Early detection of hearing impairment signals post-mRNA COVID-19 vaccination: a disproportionality analysis study on French pharmacovigilance database","volume":"48","author":"Boulefaa","year":"2025","journal-title":"Drug Saf."},{"issue":"8","key":"10.1016\/j.vaccine.2025.127549_bb0160","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.vaccine.2024.02.051","article-title":"Audiovestibular adverse events following COVID-19 vaccinations","volume":"42","author":"Shetty","year":"2024","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127549_bb0165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bjh.18627","article-title":"Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV-2 and non-SARS-CoV-2 vaccination: 32years of passive surveillance data","volume":"201","author":"Jacobs","year":"2023","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.vaccine.2025.127549_bb0170","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/pds.4038","article-title":"The validity and reliability of a signal impact assessment tool","volume":"25","author":"Rolfes","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25008461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25008461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:28:11Z","timestamp":1766546891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25008461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":34,"alternative-id":["S0264410X25008461"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127549","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strengthening spontaneous reporting-based signal detection during a pandemic with cases from electronic health records using a natural language processing tool","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127549"}}